Validating a new tool to detect cervical precancer
Part of Cancer, Infections, Women’s health & pregnancy clinical trials.
This trial is testing a new screening tool (ELEVATE) to see how well it works in detecting cervical precancer. If you have an abnormal pap smear or a positive HPV test and are scheduled for a colposcopy, you may be able to help validate this tool.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an abnormal pap smear or a recent diagnosis of cervical dysplasia (within 4 months)
- Or you have a positive HPV test (within 4 months) and have a colposcopy appointment
- You are able to understand the study materials and consent form
- You do not have heavy bleeding during the colposcopy exam
- You are not pregnant at the time of the appointment
- You have not had chemotherapy, LEEP, cryotherapy, or other cervical treatment in the past 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving women a self-collection kit to test for HPV at home can help catch cervical cancer early. It is for people who are overdue for screening and have access to a smartphone and the internet.
This study offers a way to screen for cervical cancer using an HPV self-test. It is designed for women who may not have had a recent Pap smear and are from certain minority groups.
This study tests ways to improve cervical cancer screening for women ages 30–65. It may help catch cervical cancer early or prevent it entirely by finding precancerous changes.
This study is testing a new, non-invasive way to screen for cervical cancer. It uses a photoelectric device and an epigenetic test done on a sample from your cervix. The goal is to find early signs of cancer more accurately than current methods.
This study tests a new technology to help find cervical cancer earlier by focusing on people who already had an abnormal screening result. It may help improve how abnormal tests are checked and diagnosed.
This trial studies whether letting people collect their own HPV test sample (a private, at-home option) makes cervical cancer screening easier for people with HIV and/or those who are often underserved. If you’ve declined a Pap test or it’s been 6+ months since your last screening, this may offer a more convenient way to check for HPV and cervical cancer risk.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.